SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $152,043,000 | +6.2% | 776,958 | -7.8% | 0.03% | -2.9% |
Q2 2020 | $143,226,000 | +60.0% | 842,904 | +8.7% | 0.03% | +30.8% |
Q1 2020 | $89,496,000 | +5.7% | 775,664 | +4.7% | 0.03% | +36.8% |
Q4 2019 | $84,687,000 | +37.5% | 741,178 | +2.8% | 0.02% | +26.7% |
Q3 2019 | $61,580,000 | +30.7% | 721,080 | +5.9% | 0.02% | +36.4% |
Q2 2019 | $47,118,000 | -5.2% | 680,805 | +0.3% | 0.01% | -8.3% |
Q1 2019 | $49,696,000 | +30.7% | 678,528 | +1.1% | 0.01% | +9.1% |
Q4 2018 | $38,017,000 | -19.7% | 670,962 | +9.3% | 0.01% | -8.3% |
Q3 2018 | $47,326,000 | +14.9% | 613,684 | -1.1% | 0.01% | +20.0% |
Q2 2018 | $41,193,000 | +33.9% | 620,473 | +5.6% | 0.01% | +25.0% |
Q1 2018 | $30,758,000 | +3.1% | 587,640 | +5.4% | 0.01% | 0.0% |
Q4 2017 | $29,829,000 | -2.4% | 557,563 | -0.7% | 0.01% | 0.0% |
Q3 2017 | $30,562,000 | +3.9% | 561,710 | -1.2% | 0.01% | 0.0% |
Q2 2017 | $29,406,000 | -17.4% | 568,337 | +0.4% | 0.01% | -20.0% |
Q1 2017 | $35,600,000 | +24.6% | 566,343 | +4.6% | 0.01% | +11.1% |
Q4 2016 | $28,567,000 | +27.1% | 541,366 | +30.1% | 0.01% | +28.6% |
Q3 2016 | $22,479,000 | +33.9% | 416,184 | +0.2% | 0.01% | +40.0% |
Q2 2016 | $16,786,000 | +12.2% | 415,410 | -2.4% | 0.01% | 0.0% |
Q1 2016 | $14,957,000 | -16.9% | 425,815 | +6.1% | 0.01% | -16.7% |
Q4 2015 | $18,008,000 | +19.4% | 401,250 | +2.6% | 0.01% | +20.0% |
Q3 2015 | $15,087,000 | -23.7% | 391,241 | -4.2% | 0.01% | -16.7% |
Q2 2015 | $19,761,000 | +34.8% | 408,277 | -1.5% | 0.01% | +50.0% |
Q1 2015 | $14,659,000 | +9.5% | 414,658 | -0.5% | 0.00% | 0.0% |
Q4 2014 | $13,391,000 | -24.6% | 416,751 | -12.7% | 0.00% | -33.3% |
Q3 2014 | $17,758,000 | -9.4% | 477,623 | -6.8% | 0.01% | 0.0% |
Q2 2014 | $19,601,000 | -13.6% | 512,463 | +2.9% | 0.01% | -14.3% |
Q1 2014 | $22,682,000 | +17.1% | 497,850 | +2.5% | 0.01% | +16.7% |
Q4 2013 | $19,376,000 | -10.7% | 485,757 | -1.9% | 0.01% | -25.0% |
Q3 2013 | $21,705,000 | -39.2% | 495,218 | -56.3% | 0.01% | -38.5% |
Q2 2013 | $35,685,000 | – | 1,134,265 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |